Tumour Antigen Choice - Key Publications



Publications are listed according to year, with the most recent first. Within each year, publications are listed in alphabetical order, based on the first author’s surname. Click on “Publication link” to access the publication on PubMed. Use the search box above to find particular publications based on author or terms in the title.


  • Histone deacetylase inhibitors in multiple myeloma

    Pratt G.

    Lancet Oncol. 2013 Oct;14(11):1038-9

  • Resolving the mystery of pyrophosphate antigen presentation

    Willcox CR, Mohammed F, Willcox BE.

    Nat Immunol. 2013 Sep;14(9):886-7.

  • The genotype of RAET1L (ULBP6), a ligand for human NKG2D (KLRK1), markedly influences the clinical outcome of allogeneic stem cell transplantation

    Antoun A, Vekaria D, Salama RA, Pratt G, Jobson S, Cook M, Briggs D, Moss P.

    Br J Haematol. 2012 Dec;159(5):589-98.

  • Long-term proliferation of functional human NK cells, with conversion of CD56(dim) NK cells to a CD56 (bright) phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12

    Dowell AC, Oldham KA, Bhatt RI, Lee SP, Searle PF.

    Cancer Immunol Immunother. 2012 May;61(5):615-28.

  • Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

    Goodyear OC, Dennis M, Jilani NY, Loke J, Siddique S, Ryan G, Nunnick J, Khanum R, Raghavan M, Cook M, Snowden JA, Griffiths M, Russell N, Yin J, Crawley C, Cook G, Vyas P, Moss P, Malladi R, Craddock CF.

    Blood. 2012 Apr 5;119(14):3361-9.

  • Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.

    Mura M, Swain RK, Zhuang X, Vorschmitt H, Reynolds G, Durant S, Beesley JF, Herbert JM, Sheldon H, Andre M, Sanderson S, Glen K, Luu NT, McGettrick HM, Antczak P, Falciani F, Nash GB, Nagy ZS, Bicknell R.

    Oncogene. 2012 Jan 19;31(3):293-305.